João Goulão, MD Portuguese National Drugs Coordinator President, Institute on Drugs and Drug Addiction “Leaders Against Criminalization at AIDS 2010” Vienna,

Slides:



Advertisements
Similar presentations
Drug Situation in East and Southeast Asia ARF Seminar on Narcotics Control Xi'an, China September 2007.
Advertisements

TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
João Goulão, MD Portuguese National Coordinator for Drug Problems, Drug Addictions and the Harmful Use of Alcohol General-Director of the Intervention.
Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
A call for prioritizing health and harm reduction in reforming drug policies Drug policy special session AIDS 2014 Melbourne July Dr Alex.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Global Plan to Stop TB Stop TB Partnership
The World’s Biggest Minority Left Behind: National HIV-Responses Need to and Can Include Disability Towards a UNAIDS Disability Strategy Ruben Mayorga.
1 Description of the addiction service of the Republic of Uzbekistan Jur’at Umargaliev Ministry of Health.
THE NEED FOR HARM REDUCTION THE SITUATION IN BULGARIA Bulgarian DU Activism Milena Naydenova – Hope-Sofia.
ARQ part II data management Training pack 4: Terminology.
ARQ part II data management Training pack 1: Content and conceptual issues.
Major findings from the 2013 World Drug Report. Drug use Overall drug use, including problem drug use, has remained largely stable over the past 5 years.
ESPAD – are young Europeans getting more alike? Björn Hibell EMCDDA Conference Identifying Europe's Information needs for effective drug.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
HIV Prevention and Treatment for Men who have sex with Men: Achievements and Challenges Ifeanyi Kelly Orazulike National Coordinator Sexual Minorities.
Addiction services in Georgian prisons David Otiashvili, M.D. Addiction Research Center Alternative Georgia MENTAL HEALTH AND ADDICTION IN PRISONS Bucharest,
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New.
Cristina Ribeiro, MD IDT,IP National Plan to Reduce Alcohol Related Problems A Call for Action 4th European Alcohol Policy Conference EUROCARE Brussels,
New Methamphetamine Epidemic in Thailand Apinun Aramrattana, MD, PhD Faculty of Medicine & Research Institute for Health Sciences, Chiang Mai University,
The “Sastipen Network Information System” Facing Drugs within the Roma Community: Gathering of Information for the development of indicators “The Sastipen.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
EU model – evidence based Out of 100% of people who tried drugs, only 10% get to chronicle stage Out of 100% of people who tried drugs, only 10% get to.
Drug Policies Around the World Portugal: Portugal is one of the most relevant references in the application of alternative strategies to combat drug use,
What Services Are Saying April Shaw March Survey Questions Covered Questions Covered Illicit Drug Use Illicit Drug Use Polydrug Use Polydrug Use.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
A tale of two drug policies: Portugal and Sweden Alex Stevens, PhD Professor in Criminal Justice.
Gregor Burkhart - EMCDDA / OEDT - 1 … how to deal with Risks - drugs - Gregor Burkhart, EMCDDA, July 2009 CONFERENCE ON THE HEALTH OF YOUNG PEOPLE: BE.
What is the situation in Portugal 14 years after the reformof the drug policy Rita Faria Jorge Quintas School of Criminology – Faculty of Law of the University.
Proposal on Revised Mechanism of Selecting Applications for Approval Presentation by Secretariat of Council for the AIDS Trust Fund in Sharing Session.
Social rehabilitation and reintegration of drug addicts in community – experience from EU Dr. Josef Radimecký, Ph.D., MSc. UN International Day against.
1 M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 29 – Customs union Bilateral screening:
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
João Goulão General-Director for Intervention on Addictive Behaviors and Dependencies National Coordinator on Drugs, Drug Addiction and the Harmful Use.
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
A comprehensive policy for alternatives to imprisonment: Decriminalization of drug use in Portugal and impact on Public Health Session: Alternatives to.
MODULE 3 Harm reduction advocacy
Developing reporting system for SDG and Agenda 2063, contribution of National Statistical System, issues faced and challenges CSA Ethiopia.
Harm reduction: decriminalising drug use in Asia
High level National Data Forum
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Elsa Lavado, Vasco Calado
Access Equity in Prisons in Africa A CALL FOR ACTION
Decriminalisation Policy and the role of the CDT
Alcohol drinking in pregnancy: some predictors among Portuguese women
Ludmila Carapinha, Catarina Guerreiro
Comparison of data from WBE with other sources
Founder & President of UNITE
German Drug and Addiction Policy
REITOX ACADEMY ON THE EVALUATION OF NATIONAL DRUG STRATEGIES
Skopje, 21 November 2017, General Population Survey results– launch
TEDI project (Trans European Drug Information)
Presentation transcript:

João Goulão, MD Portuguese National Drugs Coordinator President, Institute on Drugs and Drug Addiction “Leaders Against Criminalization at AIDS 2010” Vienna, 22nd July 2010 DECRIMINALIZATION OF DRUG USE IN PORTUGAL

 It began much latter than in the other Western European Countries;  It happened with relevance only after the Portuguese Democratic Revolution (1974), when society was facing lots of deep and accelerated changes;  It developed very fast, and society was not able to answer in the right time and to face the “new needs” created by drug use; as a consequence, there was a gap between the appearance of the “needs” and the “answers” The history of Drug Use in Portugal

 Drug use spread under European average level;  But a considerable number of “problematic drug users” appeared and, during a long period of time, had no access to treatment;  By the end of the 20th Century, Portugal had one of the highest prevalence of Problematic Drug Use, at European Level;  At the same time the social burden, associated to drug use, was very relevant – top political concern As a consequence of that developmental pattern:

The complexity of the situation called for some measures expected to reverse that cycle  A new National Strategy was built (1999)  A new Legal Framework appeared (Law 30/2000)  A new institutional structure appeared to implement and coordinate an Integrated Approach to all the areas related to Drugs and Drug Use

Drug consumption: not a private choice, because of its social and sanitary effects Drug addiction: a disease Drug addict: a sick person The dissuasion intervention: Opportunity for early, specific and integrated interface with consumers Aimed and targeted to the consumers’ characteristics and individual needs Decriminalization in Short João Goulão 5

Challenges A new destination for drug tourism? Compliance with the UN Conventions? Drug use increase in younger groups? Administrative sanctions in line with UN Conventions – No, Portugal said. Positive references in: April 2004 International Narcotics Control Board Mission to Portugal. World Drug Report The Cato Institute Greenwald Report. The 2009 EMCDDA Annual Report. João Goulão 6

International References 7

New Patients by Main Drug Type in Public Ambulatory 2003 – 2007 Source: IDT, I. P.: DR / DMFRI – NE * Heroin and Heroin & Cocaine categories are not directly comparable with following years categories. 8 Treatment Demand by Drug Type

9 AIDS/HIV Notifications %: Drug Addicts and Non Drug Addicts, per Year of Diagnosis, In 2005, HIV infection was included in the mandatory diseases’ notification list. ** The possibility of ongoing updates due to previous years diagnosis’ late notifications make this data provisional. INSA, I. P.: CVEDT, (2008/03/31) / IDT, I. P.: DMFRI-NE Sanitary Evidence

10 AIDS/HIV Notifications: Drug Users and Non Drug Users, per Year of Diagnosis, In 2005, HIV infection was included in the mandatory diseases’ notification list. ** The possibility of ongoing updates due to previous years diagnosis’ late notifications make this data provisional. INSA, I. P. (2008/12/31) / IDT, I. P.: DMFRI-NE Sanitary Evidence

11 Source: IDDA,.P.I.: DR / DMFRI – NE Drug Injecting on the Previous 30 days before New Patients 1st Consultation - Public Treatment Network Sanitary Evidence

PORTUGAL 2001/2007 General Population ( years ) Source: Balsa, C. - INPP Drug Consumption Prevalences (any drug) 12

PORTUGAL 2001/2007 General Population ( years) Source: Balsa, C. - INPP Drug Consumption Prevalences (any drug) 13

There is a coherent articulation among ALL THE PORTUGUESE POLICY AND ACTIONS based on the idea that a DRUG ADDICT is a SICK PERSON with treatment needs instead of being addressed as a “CRIMINAL or a DELIQUENT”. Until now, the global drug situation in Portugal, seems to have a positive evolution in all the available indicators. CONCLUSIONS:

15 INSTITUTO DA DROGA E DA TOXICODEPENDÊNCIA, I.P. INSTITUTE ON DRUGS AND DRUG ADDICTION, P.I. Thank you for your attention

Ten Days Maximum Amount Allowed Illicit Substance Chart Illicit SubstanceGrams Heroin1 Methadone1 Morphine2 Opium10 Cocaine (hydrochloride)2 Cocaine (methyl ester benzoilegonine)0.3 Cannabis (leaves and flowers or fruited dons)25 Cannabis (resin)5 Cannabis (oil)2.5 LSD0.1 MDMA1 Amphetamine1 16

Annual Distribution of the Proceedings

Indiciados Primários 2009 Situação Face aos Consumos e Encaminhamento IDT, I. P.: GAD / DMFRI - NE Toxicodependentes778 ETC. SaúdeOutrosTotal Tratamento Voluntário Encaminhamento Reencaminhamento Continuação de Tratamento Não Toxicodependentes3911 Sem Diligências de Motivação1660 Apenas Diligências de Motivação771 Dilig. Motivação + Encaminhamento p/ Estruturas de Apoio522 Encaminhamento Directo para Estruturas de Apoio958 18